Skip to main content

Table 1 Demographic and clinical characteristics of the patients

From: The importance of lower extremity involvement type on exercise performances, function, and quality of life in peripheral predominant forms of juvenile idiopathic arthritis

Characteristic

Mean (or Median) or Percentage

Gender, male rate

40%

Age, years

12.91 (SD 2.37)

BMI, kg/m2

20.23 (SD 3.87)

JIA subtype

 Oligoarticular

75%

 Polyarticular

16%

 Undifferentiated

9%

Pharmacological treatment

 Follow-up without medication

19%

 NSAID only

19%

 DMARD (with or without NSAID)

62%

Disease duration, months

41.00 (SD 38.05)

DAS28

2.85 (SD 1.23)

Hip arthritis

12.5%

Knee arthritis

28.1%

Foot/ankle arthritis

15.6%

JADI-A

0 (IQR 1) (min 0, max 8)

LED positivity rate

37.5%

6MWT, m (n: 30)

427.76 (SD 107.47)

CYC-E test duration, min

10.46 (SD 4.22)

CHAQ

0.13 (IQR 0, 0.69)

PedsQL-3A

84.37 (SD 13.45)

  1. NSAID non-steroid anti-inflammatory drug, DMARD biologic or conventional disease-modifying anti-rheumatic drug, DAS28 disease activity score 28, JADI-A Juvenile Arthritis Damage Index – Articular, LED lower extremity deformity, 6MWT 6-min walk test, CYC-E cycling exercise, CHAQ Childhood Health Assessment Questionnaire, PedsQL-3A PedsQL 3.0 Arthritis Module